Fiala

Peptide library › Immune & inflammation

Nangibotide

Also known as LR12

In clinical trialsImmune & inflammation

Experimental drip for septic shock that aims to calm an overactive immune response; it missed its main trial goal.

What people use it for

What Nangibotide does in the body

A short peptide that blocks TREM-1, a receptor that amplifies inflammation during severe infection.

Strength of evidence

Limited: the Phase 2b ASTONISH trial didn't meet its main goal, though some patient groups looked better.

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

Investigational. Not approved by the FDA.

How it's taken

Route: Drip into a vein (in trials)

How long it lasts (half-life): Short: minutes

Keep track of Nangibotide privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open Nangibotide in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Immune & inflammation